Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2014 1
2017 2
2018 1
2019 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

5 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Chronic Myelomonocytic Leukemia: Insights into Biology, Prognostic Factors, and Treatment.
Coltro G, Patnaik MM. Coltro G, et al. Curr Oncol Rep. 2019 Nov 14;21(11):101. doi: 10.1007/s11912-019-0855-6. Curr Oncol Rep. 2019. PMID: 31728739 Review.
PURPOSE OF REVIEW: Chronic myelomonocytic leukemia (CMML) is a clonal hematological malignancy characterized by both dysplastic and proliferative features, with an inherent risk for leukemic transformation. With the help of this review, we aim to summarize ke …
PURPOSE OF REVIEW: Chronic myelomonocytic leukemia (CMML) is a clonal hematological malignancy characterized by both dy …
Therapy related-chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions from de novo CMML.
Patnaik MM, Vallapureddy R, Yalniz FF, Hanson CA, Ketterling RP, Lasho TL, Finke C, Al-Kali A, Gangat N, Tefferi A. Patnaik MM, et al. Am J Hematol. 2018 Jan;93(1):65-73. doi: 10.1002/ajh.24939. Epub 2017 Nov 3. Am J Hematol. 2018. PMID: 29023992 Free article.
Therapy related myeloid neoplasms (t-MN) including therapy related myelodysplastic syndromes (t-MDS) and acute myeloid leukemia (t-AML) are associated with aggressive disease biologies and poor outcomes. In this large (n = 497) and informative (inclusi
Therapy related myeloid neoplasms (t-MN) including therapy related myelodysplastic syndromes (t-MDS) and acute myeloid leuk
Making sense of the myelodysplastic/myeloproliferative neoplasms overlap syndromes.
Tiu RV, Sekeres MA. Tiu RV, et al. Curr Opin Hematol. 2014 Mar;21(2):131-40. doi: 10.1097/MOH.0000000000000021. Curr Opin Hematol. 2014. PMID: 24378705 Review.
PURPOSE OF REVIEW: Myelodysplastic/myeloproliferative neoplasms (MDS/MPNs), including chronic myelomonocytic leukemia, atypical chronic myeloid leukemia, MDS/MPN-Unclassifiable, ring sideroblasts associated with marked thrombocytosis, and juveni …
PURPOSE OF REVIEW: Myelodysplastic/myeloproliferative neoplasms (MDS/MPNs), including chronic myelomonocytic leukemia, …
Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.
Liu HD, Ahn KW, Hu ZH, Hamadani M, Nishihori T, Wirk B, Beitinjaneh A, Rizzieri D, Grunwald MR, Sabloff M, Olsson RF, Bajel A, Bredeson C, Daly A, Inamoto Y, Majhail N, Saad A, Gupta V, Gerds A, Malone A, Tallman M, Reshef R, Marks DI, Copelan E, Gergis U, Savoie ML, Ustun C, Litzow MR, Cahn JY, Kindwall-Keller T, Akpek G, Savani BN, Aljurf M, Rowe JM, Wiernik PH, Hsu JW, Cortes J, Kalaycio M, Maziarz R, Sobecks R, Popat U, Alyea E, Saber W. Liu HD, et al. Biol Blood Marrow Transplant. 2017 May;23(5):767-775. doi: 10.1016/j.bbmt.2017.01.078. Epub 2017 Jan 20. Biol Blood Marrow Transplant. 2017. PMID: 28115276 Free PMC article.
Allogeneic hematopoietic cell transplantation (HCT) is potentially curative for patients with chronic myelomonocytic leukemia (CMML); however, few data exist regarding prognostic factors and transplantation outcomes. We performed this retrospect …
Allogeneic hematopoietic cell transplantation (HCT) is potentially curative for patients with chronic myelomonocytic leukem
Karyotypic analysis in primary myelodysplastic syndromes.
Noël P, Tefferi A, Pierre RV, Jenkins RB, Dewald GW. Noël P, et al. Blood Rev. 1993 Mar;7(1):10-8. doi: 10.1016/0268-960x(93)90019-z. Blood Rev. 1993. PMID: 8467227 Review.
Cytogenetics has provided new insights into the biology and pathogenesis of myelodysplastic syndromes. In patients with refractory anemia, it has provided proof of clonality and has helped differentiate chronic myelomonocytic leukemia from ch
Cytogenetics has provided new insights into the biology and pathogenesis of myelodysplastic syndromes. In patients with refrac …